Cardiac Biomarkers in Patients With Single Ventricle Physiology

Completed

Conditions studied: Hypoplastic Left Heart, Congenital Heart Disease, Cyanotic Congenital Heart Disease, Cardiac Disease

In brief

All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-type natriuretic peptide (BNP) and Troponin level before the surgical procedure, on arrival to the cardiac intensive care unit after their surgical procedure, every 6 hours during the first 24 hours of the post-operative period, followed by daily levels for the first week, and then weekly during patient's regular laboratory work up schedule. These cardiac biomarkers are linked to demographic, hemodynamic, respiratory, pharmacological data available via Sickbay.

Key facts

Study ID

NCT03678909

Run by

Baylor College of Medicine

People needed

19

Starts

2018-03-01

Expected to finish

2020-07-30

Last updated by the study team

2020-08-03

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of Hypoplastic Left Heart Syndrome as congenital heart disease as a neonate

You may not qualify if…

• Other diagnosis of congenital heart disease than Hypoplastic Left Heart Syndrome Patients older than 30 days

Where it is running

• Texas Children's Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.